The instruments for peptide drug synthesis market is projected to grow from USD 229.5 million in 2025 to USD 486.4 million by 2035, at a CAGR of 7.8%. Peptide synthesizer will dominate with a 37.0% market share, while pharmaceutical and biotechnology companies will lead the application segment with a 52.0% share.